The Cytidine Deaminase APOBEC3 Family Is Subject to Transcriptional Regulation by p53
The APOBEC3 (A3) family of proteins are DNA cytidine deaminases that act as sentinels in the innate immune response against retroviral infections and are responsive to IFN. Recently, a few A3 genes were identified as potent enzymatic sources of mutations in several human cancers. Using human cancer...
Saved in:
Published in | Molecular cancer research Vol. 15; no. 6; pp. 735 - 743 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
United States
American Association for Cancer Research Inc
01.06.2017
|
Subjects | |
Online Access | Get full text |
ISSN | 1541-7786 1557-3125 1557-3125 |
DOI | 10.1158/1541-7786.MCR-17-0019 |
Cover
Abstract | The APOBEC3 (A3) family of proteins are DNA cytidine deaminases that act as sentinels in the innate immune response against retroviral infections and are responsive to IFN. Recently, a few A3 genes were identified as potent enzymatic sources of mutations in several human cancers. Using human cancer cells and lymphocytes, we show that under stress conditions and immune challenges, all A3 genes are direct transcriptional targets of the tumor suppressor p53. Although the expression of most A3 genes (including A3C and A3H) was stimulated by the activation of p53, treatment with the DNA-damaging agent doxorubicin or the p53 stabilizer Nutlin led to repression of the A3B gene. Furthermore, p53 could enhance IFN type-I induction of A3 genes. Interestingly, overexpression of a group of tumor-associated p53 mutants in TP53-null cancer cells promoted A3B expression. These findings establish that the "guardian of the genome" role ascribed to p53 also extends to a unique component of the immune system, the A3 genes, thereby integrating human immune and chromosomal stress responses into an A3/p53 immune axis.
Implications: Activated p53 can integrate chromosomal stresses and immune responses through its influence on expression of APOBEC3 genes, which are key components of the innate immune system that also influence genomic stability. Mol Cancer Res; 15(6); 735–44. ©2017 AACR. |
---|---|
AbstractList | The APOBEC3 (A3) family of proteins are DNA cytidine deaminases that act as sentinels in the innate immune response against retroviral infections and are responsive to IFN. Recently, a few
genes were identified as potent enzymatic sources of mutations in several human cancers. Using human cancer cells and lymphocytes, we show that under stress conditions and immune challenges, all
genes are direct transcriptional targets of the tumor suppressor p53. Although the expression of most
genes (including
and
) was stimulated by the activation of p53, treatment with the DNA-damaging agent doxorubicin or the p53 stabilizer Nutlin led to repression of the
gene. Furthermore, p53 could enhance IFN type-I induction of
genes. Interestingly, overexpression of a group of tumor-associated p53 mutants in
-null cancer cells promoted
expression. These findings establish that the "guardian of the genome" role ascribed to p53 also extends to a unique component of the immune system, the
genes, thereby integrating human immune and chromosomal stress responses into an A3/p53 immune axis.
Activated p53 can integrate chromosomal stresses and immune responses through its influence on expression of
genes, which are key components of the innate immune system that also influence genomic stability.
. The APOBEC3 (A3) family of proteins are DNA cytidine deaminases that act as sentinels in the innate immune response against retroviral infections and are responsive to IFN. Recently, a few A3 genes were identified as potent enzymatic sources of mutations in several human cancers. Using human cancer cells and lymphocytes, we show that under stress conditions and immune challenges, all A3 genes are direct transcriptional targets of the tumor suppressor p53. Although the expression of most A3 genes (including A3C and A3H) was stimulated by the activation of p53, treatment with the DNA-damaging agent doxorubicin or the p53 stabilizer Nutlin led to repression of the A3B gene. Furthermore, p53 could enhance IFN type-I induction of A3 genes. Interestingly, overexpression of a group of tumor-associated p53 mutants in TP53-null cancer cells promoted A3B expression. These findings establish that the "guardian of the genome" role ascribed to p53 also extends to a unique component of the immune system, the A3 genes, thereby integrating human immune and chromosomal stress responses into an A3/p53 immune axis.Implications: Activated p53 can integrate chromosomal stresses and immune responses through its influence on expression of APOBEC3 genes, which are key components of the innate immune system that also influence genomic stability. Mol Cancer Res; 15(6); 735–44. ©2017 AACR. The APOBEC3 (A3) family of proteins are DNA cytidine deaminases that act as sentinels in the innate immune response against retroviral infections and are responsive to IFN. Recently, a few A3 genes were identified as potent enzymatic sources of mutations in several human cancers. Using human cancer cells and lymphocytes, we show that under stress conditions and immune challenges, all A3 genes are direct transcriptional targets of the tumor suppressor p53. Although the expression of most A3 genes (including A3C and A3H) was stimulated by the activation of p53, treatment with the DNA-damaging agent doxorubicin or the p53 stabilizer Nutlin led to repression of the A3B gene. Furthermore, p53 could enhance IFN type-I induction of A3 genes. Interestingly, overexpression of a group of tumor-associated p53 mutants in TP53-null cancer cells promoted A3B expression. These findings establish that the "guardian of the genome" role ascribed to p53 also extends to a unique component of the immune system, the A3 genes, thereby integrating human immune and chromosomal stress responses into an A3/p53 immune axis.Implications: Activated p53 can integrate chromosomal stresses and immune responses through its influence on expression of APOBEC3 genes, which are key components of the innate immune system that also influence genomic stability. Mol Cancer Res; 15(6); 735-44. [copy2017 AACR. The APOBEC3 (A3) family of proteins are DNA cytidine deaminases that act as sentinels in the innate immune response against retroviral infections and are responsive to IFN. Recently, a few A3 genes were identified as potent enzymatic sources of mutations in several human cancers. Using human cancer cells and lymphocytes, we show that under stress conditions and immune challenges, all A3 genes are direct transcriptional targets of the tumor suppressor p53. Although the expression of most A3 genes (including A3C and A3H) was stimulated by the activation of p53, treatment with the DNA-damaging agent doxorubicin or the p53 stabilizer Nutlin led to repression of the A3B gene. Furthermore, p53 could enhance IFN type-I induction of A3 genes. Interestingly, overexpression of a group of tumor-associated p53 mutants in TP53-null cancer cells promoted A3B expression. These findings establish that the "guardian of the genome" role ascribed to p53 also extends to a unique component of the immune system, the A3 genes, thereby integrating human immune and chromosomal stress responses into an A3/p53 immune axis. Implications: Activated p53 can integrate chromosomal stresses and immune responses through its influence on expression of APOBEC3 genes, which are key components of the innate immune system that also influence genomic stability. Mol Cancer Res; 15(6); 735–44. ©2017 AACR. The APOBEC3 (A3) family of proteins are DNA cytidine deaminases that act as sentinels in the innate immune response against retroviral infections and are responsive to interferon. Recently, a few A3 genes were identified as potent enzymatic sources of mutations in several human cancers. Using human cancer cells and lymphocytes we show that under stress conditions and immune challenges all A3 genes are direct transcriptional targets of the tumor suppressor p53. While the expression of most A3 genes (including A3C and A3H) was stimulated by activation of p53, treatment with the DNA damaging agent doxorubicin or the p53 stabilizer Nutlin, led to repression of the A3B gene. Furthermore, p53 could enhance interferon type-I induction of A3 genes. Interestingly, overexpression of a group of tumor-associated p53 mutants in TP53-null cancer cells promoted A3B expression. These findings establish that the “guardian of the genome” role ascribed to p53 also extends to a unique component of the immune system–the A3 genes–thereby integrating human immune and chromosomal stress responses into an A3/p53 immune axis. The APOBEC3 (A3) family of proteins are DNA cytidine deaminases that act as sentinels in the innate immune response against retroviral infections and are responsive to IFN. Recently, a few A3 genes were identified as potent enzymatic sources of mutations in several human cancers. Using human cancer cells and lymphocytes, we show that under stress conditions and immune challenges, all A3 genes are direct transcriptional targets of the tumor suppressor p53. Although the expression of most A3 genes (including A3C and A3H) was stimulated by the activation of p53, treatment with the DNA-damaging agent doxorubicin or the p53 stabilizer Nutlin led to repression of the A3B gene. Furthermore, p53 could enhance IFN type-I induction of A3 genes. Interestingly, overexpression of a group of tumor-associated p53 mutants in TP53-null cancer cells promoted A3B expression. These findings establish that the "guardian of the genome" role ascribed to p53 also extends to a unique component of the immune system, the A3 genes, thereby integrating human immune and chromosomal stress responses into an A3/p53 immune axis.Implications: Activated p53 can integrate chromosomal stresses and immune responses through its influence on expression of APOBEC3 genes, which are key components of the innate immune system that also influence genomic stability. Mol Cancer Res; 15(6); 735-44. ©2017 AACR.The APOBEC3 (A3) family of proteins are DNA cytidine deaminases that act as sentinels in the innate immune response against retroviral infections and are responsive to IFN. Recently, a few A3 genes were identified as potent enzymatic sources of mutations in several human cancers. Using human cancer cells and lymphocytes, we show that under stress conditions and immune challenges, all A3 genes are direct transcriptional targets of the tumor suppressor p53. Although the expression of most A3 genes (including A3C and A3H) was stimulated by the activation of p53, treatment with the DNA-damaging agent doxorubicin or the p53 stabilizer Nutlin led to repression of the A3B gene. Furthermore, p53 could enhance IFN type-I induction of A3 genes. Interestingly, overexpression of a group of tumor-associated p53 mutants in TP53-null cancer cells promoted A3B expression. These findings establish that the "guardian of the genome" role ascribed to p53 also extends to a unique component of the immune system, the A3 genes, thereby integrating human immune and chromosomal stress responses into an A3/p53 immune axis.Implications: Activated p53 can integrate chromosomal stresses and immune responses through its influence on expression of APOBEC3 genes, which are key components of the innate immune system that also influence genomic stability. Mol Cancer Res; 15(6); 735-44. ©2017 AACR. |
Author | Menendez, Daniel Resnick, Michael A. Nguyen, Thuy-Ai Snipe, Joyce |
AuthorAffiliation | 1 Genome Integrity and Structural Biology Laboratory, National Institute of Environmental Health Sciences, NIH, Research Triangle Park, NC 27709, USA |
AuthorAffiliation_xml | – name: 1 Genome Integrity and Structural Biology Laboratory, National Institute of Environmental Health Sciences, NIH, Research Triangle Park, NC 27709, USA |
Author_xml | – sequence: 1 givenname: Daniel surname: Menendez fullname: Menendez, Daniel – sequence: 2 givenname: Thuy-Ai surname: Nguyen fullname: Nguyen, Thuy-Ai – sequence: 3 givenname: Joyce surname: Snipe fullname: Snipe, Joyce – sequence: 4 givenname: Michael A. surname: Resnick fullname: Resnick, Michael A. |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/28232385$$D View this record in MEDLINE/PubMed |
BookMark | eNqNkl1rFDEUhoNU7If-BCXgjTdTc5LNF4JQp60WKpW6vQ5JJtNmmZ2skxlh_30zdi3aG71KcvKcl5fznkO016c-IPQayDEAV--BL6CSUonjr_V1BbIiBPQzdACcy4oB5Xvzfcfso8OcV4RQAlK8QPtUUUaZ4gfoZnkXcL0dYxP7gE-DXcfe5oBPvl19OqsZPi-FbosvMv4-uVXwIx4TXg62z36ImzGm3nb4OtxOnZ0f2G3xhrOX6Hlruxxe7c4jdHN-tqy_VJdXny_qk8vKc6bGKngHrWRB0aCkWDRCB9eCFbqRLTjvSMs1U4QIrRtPNeOcOqopgLd-4YrGEfr4oLuZ3Do0PvTjYDuzGeLaDluTbDR___Txztymn4YvuJQgi8C7ncCQfkwhj2Ydsw9dZ_uQpmxAAwjQhP0HqiTlUgtBCvr2CbpK01AmNQuqMncQcjb_5k_zj65_h1MA_gD4IeU8hPYRAWLmJTBzwGYO2JQlMCDNvASl78OTPh_HX_GUGcTuH9336aO10Q |
CitedBy_id | crossref_primary_10_1038_s41587_020_0551_y crossref_primary_10_1002_JLB_2MR0717_310R crossref_primary_10_1111_sji_12760 crossref_primary_10_1016_j_mrrev_2022_108411 crossref_primary_10_3390_ijms21186865 crossref_primary_10_1093_nar_gky720 crossref_primary_10_18632_oncotarget_28195 crossref_primary_10_1093_carcin_bgaa002 crossref_primary_10_1038_s41388_020_01583_7 crossref_primary_10_1038_s41467_020_14730_1 crossref_primary_10_1038_s41588_022_01196_8 crossref_primary_10_1080_14796694_2024_2442300 crossref_primary_10_1093_jmcb_mjz075 crossref_primary_10_1038_s41598_024_64986_6 crossref_primary_10_3389_fmicb_2018_02088 crossref_primary_10_3390_ijms26030989 crossref_primary_10_1371_journal_pgen_1011293 crossref_primary_10_1016_j_celrep_2019_02_028 crossref_primary_10_1038_s41388_020_1225_4 crossref_primary_10_1021_acs_chemrestox_9b00358 crossref_primary_10_1371_journal_pone_0241482 crossref_primary_10_1098_rsob_200188 crossref_primary_10_1093_nar_gky1316 crossref_primary_10_1016_j_cell_2017_08_028 crossref_primary_10_1111_cas_13658 crossref_primary_10_1111_febs_16202 crossref_primary_10_1172_JCI128626 crossref_primary_10_7554_eLife_61287 crossref_primary_10_1093_nar_gkab551 crossref_primary_10_3390_ijms242316793 crossref_primary_10_3390_v9080233 crossref_primary_10_1146_annurev_genet_072920_035840 |
Cites_doi | 10.1158/0008-5472.CAN-11-4134 10.1016/j.ccr.2014.01.021 10.1101/gad.266098.115 10.1073/pnas.0909129107 10.1038/ng.2701 10.1038/nature01850 10.1016/j.coviro.2011.10.008 10.1038/embor.2011.46 10.1099/jgv.0.000320 10.1158/0008-5472.CAN-13-1753 10.1002/rmv.1738 10.1371/journal.pgen.1001360 10.1093/nar/gkn232 10.1016/S0092-8674(02)00839-5 10.1093/nar/gkt504 10.1126/science.285.5434.1733 10.1084/jem.20080521 10.1016/j.molcel.2010.09.019 10.1186/s13059-016-1042-9 10.1038/ng.2702 10.1093/molbev/msi026 10.1016/j.cell.2005.10.043 10.1006/geno.2002.6718 10.1038/ng.3670 10.1128/JVI.01089-09 10.1200/JCO.2014.59.5728 10.4161/mge.1.3.17430 10.7554/eLife.02200 10.1002/bies.201600031 10.1016/j.cell.2006.12.007 10.1038/nrc2730 10.1101/cshperspect.a026062 10.1128/mBio.02234-14 10.1016/j.cell.2010.05.021 10.1016/j.virol.2015.03.012 10.1093/nar/gkm340 10.1016/j.bbrc.2016.08.148 10.1038/nature05541 10.18632/oncotarget.11210 10.1084/jem.20080383 10.1186/s40246-015-0056-9 10.1038/ncomms12918 10.1038/nrc3711 10.1038/ng.2955 10.18632/oncotarget.4435 10.1038/ng.3378 10.1093/nar/gkq174 10.1126/science.1068999 10.4049/jimmunol.1501504 10.1093/nar/gkm181 |
ContentType | Journal Article |
Copyright | 2017 American Association for Cancer Research. Copyright American Association for Cancer Research Inc Jun 2017 |
Copyright_xml | – notice: 2017 American Association for Cancer Research. – notice: Copyright American Association for Cancer Research Inc Jun 2017 |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7TO 7U7 C1K H94 7X8 5PM |
DOI | 10.1158/1541-7786.MCR-17-0019 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Oncogenes and Growth Factors Abstracts Toxicology Abstracts Environmental Sciences and Pollution Management AIDS and Cancer Research Abstracts MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) AIDS and Cancer Research Abstracts Oncogenes and Growth Factors Abstracts Toxicology Abstracts Environmental Sciences and Pollution Management MEDLINE - Academic |
DatabaseTitleList | MEDLINE AIDS and Cancer Research Abstracts Oncogenes and Growth Factors Abstracts CrossRef MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Biology |
EISSN | 1557-3125 |
EndPage | 743 |
ExternalDocumentID | PMC5457717 28232385 10_1158_1541_7786_MCR_17_0019 |
Genre | Journal Article |
GrantInformation_xml | – fundername: Intramural NIH HHS grantid: Z01 ES065079 – fundername: Intramural NIH HHS grantid: ZIA ES065079 |
GroupedDBID | --- 123 18M 2FS 2WC 34G 39C 53G 5RE 5VS AAJMC AAYXX ACGFO ACPRK ADBBV ADCOW AENEX AFHIN AFRAH AFUMD ALMA_UNASSIGNED_HOLDINGS BAWUL BR6 BTFSW CITATION CS3 DIK DU5 E3Z EBS EJD F5P GX1 H13 HH5 IH2 KQ8 L7B OK1 QTD RCR RHI TR2 W8F WOQ YKV .55 .GJ 3O- ABEFU AFFNX C1A CGR CUY CVF ECM EIF H~9 MVM NPM WHG X7M ZGI 7TO 7U7 C1K H94 7X8 5PM |
ID | FETCH-LOGICAL-c538t-ecb1f73e82e8764d69ebf1a69d7f1bcb0f593800699dc293552b29211cac4bc53 |
ISSN | 1541-7786 1557-3125 |
IngestDate | Thu Aug 21 14:11:47 EDT 2025 Thu Sep 04 23:05:28 EDT 2025 Fri Sep 05 10:56:35 EDT 2025 Mon Jun 30 16:42:08 EDT 2025 Sat May 31 02:13:53 EDT 2025 Tue Jul 01 04:31:25 EDT 2025 Thu Apr 24 22:57:59 EDT 2025 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 6 |
Language | English |
License | 2017 American Association for Cancer Research. |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c538t-ecb1f73e82e8764d69ebf1a69d7f1bcb0f593800699dc293552b29211cac4bc53 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
OpenAccessLink | https://www.ncbi.nlm.nih.gov/pmc/articles/5457717 |
PMID | 28232385 |
PQID | 1983851675 |
PQPubID | 2046228 |
PageCount | 9 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_5457717 proquest_miscellaneous_1911619037 proquest_miscellaneous_1872579660 proquest_journals_1983851675 pubmed_primary_28232385 crossref_primary_10_1158_1541_7786_MCR_17_0019 crossref_citationtrail_10_1158_1541_7786_MCR_17_0019 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2017-06-01 |
PublicationDateYYYYMMDD | 2017-06-01 |
PublicationDate_xml | – month: 06 year: 2017 text: 2017-06-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States – name: Philadelphia |
PublicationTitle | Molecular cancer research |
PublicationTitleAlternate | Mol Cancer Res |
PublicationYear | 2017 |
Publisher | American Association for Cancer Research Inc |
Publisher_xml | – name: American Association for Cancer Research Inc |
References | Muller (2022060706540422400_bib40) 2014; 25 Maruyama (2022060706540422400_bib41) 2016; 478 Koito (2022060706540422400_bib29) 2011; 1 Martins (2022060706540422400_bib5) 2006; 127 Shatz (2022060706540422400_bib11) 2015; 6 Kanu (2022060706540422400_bib31) 2016; 17 Ventura (2022060706540422400_bib6) 2007; 445 Menendez (2022060706540422400_bib26) 2010; 107 Harris (2022060706540422400_bib13) 2015; 479–80 Takaoka (2022060706540422400_bib27) 2003; 424 Sato (2022060706540422400_bib32) 2013; 23 Menendez (2022060706540422400_bib8) 2011; 7 Refsland (2022060706540422400_bib19) 2010; 38 Brummelkamp (2022060706540422400_bib22) 2002; 296 Landry (2022060706540422400_bib43) 2011; 12 Nik-Zainal (2022060706540422400_bib46) 2014; 46 Munoz-Fontela (2022060706540422400_bib7) 2008; 205 Symer (2022060706540422400_bib36) 2002; 110 Allen (2022060706540422400_bib2) 2014; 3 Bieging (2022060706540422400_bib4) 2014; 14 Schoggins (2022060706540422400_bib33) 2011; 1 Conticello (2022060706540422400_bib20) 2005; 22 Levine (2022060706540422400_bib35) 2016; 38 Aubrey (2022060706540422400_bib1) 2016; 6 Roberts (2022060706540422400_bib17) 2013; 45 Menendez (2022060706540422400_bib3) 2013; 41 Burns (2022060706540422400_bib15) 2013; 45 Middlebrooks (2022060706540422400_bib47) 2016; 48 Komarov (2022060706540422400_bib21) 1999; 285 Stavrou (2022060706540422400_bib14) 2015; 195 Muckenfuss (2022060706540422400_bib38) 2007; 35 Pauklin (2022060706540422400_bib30) 2009; 206 Wylie (2022060706540422400_bib37) 2016; 30 Wei (2022060706540422400_bib25) 2006; 124 Ciccia (2022060706540422400_bib45) 2010; 40 Vieira (2022060706540422400_bib42) 2014; 5 Shatz (2022060706540422400_bib9) 2012; 72 Starrett (2022060706540422400_bib49) 2016; 7 Menendez (2022060706540422400_bib10) 2016; 7 Bougeard (2022060706540422400_bib50) 2015; 33 Zhang (2022060706540422400_bib48) 2015; 9 Leonard (2022060706540422400_bib39) 2013; 73 Kinomoto (2022060706540422400_bib28) 2007; 35 Menendez (2022060706540422400_bib23) 2009; 9 Wang (2022060706540422400_bib44) 2016; 97 Jarmuz (2022060706540422400_bib12) 2002; 79 Beck (2022060706540422400_bib34) 2010; 141 Chan (2022060706540422400_bib16) 2015; 47 Smeenk (2022060706540422400_bib24) 2008; 36 Koning (2022060706540422400_bib18) 2009; 83 |
References_xml | – volume: 72 start-page: 3948 year: 2012 ident: 2022060706540422400_bib9 article-title: The human TLR innate immune gene family is differentially influenced by DNA stress and p53 status in cancer cells publication-title: Cancer Res doi: 10.1158/0008-5472.CAN-11-4134 – volume: 25 start-page: 304 year: 2014 ident: 2022060706540422400_bib40 article-title: Mutant p53 in cancer: new functions and therapeutic opportunities publication-title: Cancer Cell doi: 10.1016/j.ccr.2014.01.021 – volume: 30 start-page: 64 year: 2016 ident: 2022060706540422400_bib37 article-title: p53 genes function to restrain mobile elements publication-title: Genes Dev doi: 10.1101/gad.266098.115 – volume: 107 start-page: 1500 year: 2010 ident: 2022060706540422400_bib26 article-title: Estrogen receptor acting in cis enhances WT and mutant p53 transactivation at canonical and noncanonical p53 target sequences publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.0909129107 – volume: 45 start-page: 977 year: 2013 ident: 2022060706540422400_bib15 article-title: Evidence for APOBEC3B mutagenesis in multiple human cancers publication-title: Nat Genet doi: 10.1038/ng.2701 – volume: 424 start-page: 516 year: 2003 ident: 2022060706540422400_bib27 article-title: Integration of interferon-alpha/beta signalling to p53 responses in tumour suppression and antiviral defence publication-title: Nature doi: 10.1038/nature01850 – volume: 1 start-page: 519 year: 2011 ident: 2022060706540422400_bib33 article-title: Interferon-stimulated genes and their antiviral effector functions publication-title: Curr Opin Virol doi: 10.1016/j.coviro.2011.10.008 – volume: 12 start-page: 444 year: 2011 ident: 2022060706540422400_bib43 article-title: APOBEC3A can activate the DNA damage response and cause cell-cycle arrest publication-title: EMBO Rep doi: 10.1038/embor.2011.46 – volume: 97 start-page: 1 year: 2016 ident: 2022060706540422400_bib44 article-title: Role of the single deaminase domain APOBEC3A in virus restriction, retrotransposition, DNA damage and cancer publication-title: J Gen Virol doi: 10.1099/jgv.0.000320 – volume: 73 start-page: 7222 year: 2013 ident: 2022060706540422400_bib39 article-title: APOBEC3B upregulation and genomic mutation patterns in serous ovarian carcinoma publication-title: Cancer Res doi: 10.1158/0008-5472.CAN-13-1753 – volume: 23 start-page: 213 year: 2013 ident: 2022060706540422400_bib32 article-title: Genome guardian p53 and viral infections publication-title: Rev Med Virol doi: 10.1002/rmv.1738 – volume: 7 start-page: e1001360 year: 2011 ident: 2022060706540422400_bib8 article-title: The Toll-like receptor gene family is integrated into human DNA damage and p53 networks publication-title: PLoS Genet doi: 10.1371/journal.pgen.1001360 – volume: 36 start-page: 3639 year: 2008 ident: 2022060706540422400_bib24 article-title: Characterization of genome-wide p53-binding sites upon stress response publication-title: Nucleic Acids Res doi: 10.1093/nar/gkn232 – volume: 110 start-page: 327 year: 2002 ident: 2022060706540422400_bib36 article-title: Human l1 retrotransposition is associated with genetic instability in vivo publication-title: Cell doi: 10.1016/S0092-8674(02)00839-5 – volume: 41 start-page: 7286 year: 2013 ident: 2022060706540422400_bib3 article-title: Diverse stresses dramatically alter genome-wide p53 binding and transactivation landscape in human cancer cells publication-title: Nucleic Acids Res doi: 10.1093/nar/gkt504 – volume: 285 start-page: 1733 year: 1999 ident: 2022060706540422400_bib21 article-title: A chemical inhibitor of p53 that protects mice from the side effects of cancer therapy publication-title: Science doi: 10.1126/science.285.5434.1733 – volume: 206 start-page: 99 year: 2009 ident: 2022060706540422400_bib30 article-title: Estrogen directly activates AID transcription and function publication-title: J Exp Med doi: 10.1084/jem.20080521 – volume: 40 start-page: 179 year: 2010 ident: 2022060706540422400_bib45 article-title: The DNA damage response: making it safe to play with knives publication-title: Mol Cell doi: 10.1016/j.molcel.2010.09.019 – volume: 17 start-page: 185 year: 2016 ident: 2022060706540422400_bib31 article-title: DNA replication stress mediates APOBEC3 family mutagenesis in breast cancer publication-title: Genome Biol doi: 10.1186/s13059-016-1042-9 – volume: 45 start-page: 970 year: 2013 ident: 2022060706540422400_bib17 article-title: An APOBEC cytidine deaminase mutagenesis pattern is widespread in human cancers publication-title: Nat Genet doi: 10.1038/ng.2702 – volume: 22 start-page: 367 year: 2005 ident: 2022060706540422400_bib20 article-title: Evolution of the AID/APOBEC family of polynucleotide (deoxy)cytidine deaminases publication-title: Mol Biol Evol doi: 10.1093/molbev/msi026 – volume: 124 start-page: 207 year: 2006 ident: 2022060706540422400_bib25 article-title: A global map of p53 transcription-factor binding sites in the human genome publication-title: Cell doi: 10.1016/j.cell.2005.10.043 – volume: 79 start-page: 285 year: 2002 ident: 2022060706540422400_bib12 article-title: An anthropoid-specific locus of orphan C to U RNA-editing enzymes on chromosome 22 publication-title: Genomics doi: 10.1006/geno.2002.6718 – volume: 48 start-page: 1330 year: 2016 ident: 2022060706540422400_bib47 article-title: Association of germline variants in the APOBEC3 region with cancer risk and enrichment with APOBEC-signature mutations in tumors publication-title: Nat Genet doi: 10.1038/ng.3670 – volume: 83 start-page: 9474 year: 2009 ident: 2022060706540422400_bib18 article-title: Defining APOBEC3 expression patterns in human tissues and hematopoietic cell subsets publication-title: J Virol doi: 10.1128/JVI.01089-09 – volume: 33 start-page: 2345 year: 2015 ident: 2022060706540422400_bib50 article-title: Revisiting Li-Fraumeni syndrome from TP53 mutation carriers publication-title: J Clin Oncol doi: 10.1200/JCO.2014.59.5728 – volume: 1 start-page: 197 year: 2011 ident: 2022060706540422400_bib29 article-title: Intrinsic restriction activity by AID/APOBEC family of enzymes against the mobility of retroelements publication-title: Mob Genet Elements doi: 10.4161/mge.1.3.17430 – volume: 3 start-page: e02200 year: 2014 ident: 2022060706540422400_bib2 article-title: Global analysis of p53-regulated transcription identifies its direct targets and unexpected regulatory mechanisms publication-title: Elife doi: 10.7554/eLife.02200 – volume: 38 start-page: 508 year: 2016 ident: 2022060706540422400_bib35 article-title: P53 and the defenses against genome instability caused by transposons and repetitive elements publication-title: Bioessays doi: 10.1002/bies.201600031 – volume: 127 start-page: 1323 year: 2006 ident: 2022060706540422400_bib5 article-title: Modeling the therapeutic efficacy of p53 restoration in tumors publication-title: Cell doi: 10.1016/j.cell.2006.12.007 – volume: 9 start-page: 724 year: 2009 ident: 2022060706540422400_bib23 article-title: The expanding universe of p53 targets publication-title: Nat Rev Cancer doi: 10.1038/nrc2730 – volume: 6 start-page: pii:a026062 year: 2016 ident: 2022060706540422400_bib1 article-title: Tumor-suppressor functions of the TP53 pathway publication-title: Cold Spring Harb Perspect Med doi: 10.1101/cshperspect.a026062 – volume: 5 start-page: pii:e02234–14 year: 2014 ident: 2022060706540422400_bib42 article-title: Human papillomavirus E6 triggers upregulation of the antiviral and cancer genomic DNA deaminase APOBEC3B publication-title: MBio doi: 10.1128/mBio.02234-14 – volume: 141 start-page: 1159 year: 2010 ident: 2022060706540422400_bib34 article-title: LINE-1 retrotransposition activity in human genomes publication-title: Cell doi: 10.1016/j.cell.2010.05.021 – volume: 479–80 start-page: 131 year: 2015 ident: 2022060706540422400_bib13 article-title: APOBECs and virus restriction publication-title: Virology doi: 10.1016/j.virol.2015.03.012 – volume: 35 start-page: 3784 year: 2007 ident: 2022060706540422400_bib38 article-title: Sp1 and Sp3 regulate basal transcription of the human APOBEC3G gene publication-title: Nucleic Acids Res doi: 10.1093/nar/gkm340 – volume: 478 start-page: 1466 year: 2016 ident: 2022060706540422400_bib41 article-title: Classical NF-κB pathway is responsible for APOBEC3B expression in cancer cells publication-title: Biochem Biophys Res Commun doi: 10.1016/j.bbrc.2016.08.148 – volume: 445 start-page: 661 year: 2007 ident: 2022060706540422400_bib6 article-title: Restoration of p53 function leads to tumour regression in vivo publication-title: Nature doi: 10.1038/nature05541 – volume: 7 start-page: 61630 year: 2016 ident: 2022060706540422400_bib10 article-title: Ligand dependent restoration of human TLR3 signaling and death in p53 mutant cells publication-title: Oncotarget doi: 10.18632/oncotarget.11210 – volume: 205 start-page: 1929 year: 2008 ident: 2022060706540422400_bib7 article-title: Transcriptional role of p53 in interferon-mediated antiviral immunity publication-title: J Exp Med doi: 10.1084/jem.20080383 – volume: 9 start-page: 34 year: 2015 ident: 2022060706540422400_bib48 article-title: Integrative genomic analysis reveals functional diversification of APOBEC gene family in breast cancer publication-title: Hum Genomics doi: 10.1186/s40246-015-0056-9 – volume: 7 start-page: 12918 year: 2016 ident: 2022060706540422400_bib49 article-title: The DNA cytosine deaminase APOBEC3H haplotype I likely contributes to breast and lung cancer mutagenesis publication-title: Nat Commun doi: 10.1038/ncomms12918 – volume: 14 start-page: 359 year: 2014 ident: 2022060706540422400_bib4 article-title: Unravelling mechanisms of p53-mediated tumour suppression publication-title: Nat Rev Cancer doi: 10.1038/nrc3711 – volume: 46 start-page: 487 year: 2014 ident: 2022060706540422400_bib46 article-title: Association of a germline copy number polymorphism of APOBEC3A and APOBEC3B with burden of putative APOBEC-dependent mutations in breast cancer publication-title: Nat Genet doi: 10.1038/ng.2955 – volume: 6 start-page: 16963 year: 2015 ident: 2022060706540422400_bib11 article-title: p53 amplifies Toll-like receptor 5 response in human primary and cancer cells through interaction with multiple signal transduction pathways publication-title: Oncotarget doi: 10.18632/oncotarget.4435 – volume: 47 start-page: 1067 year: 2015 ident: 2022060706540422400_bib16 article-title: An APOBEC3A hypermutation signature is distinguishable from the signature of background mutagenesis by APOBEC3B in human cancers publication-title: Nat Genet doi: 10.1038/ng.3378 – volume: 38 start-page: 4274 year: 2010 ident: 2022060706540422400_bib19 article-title: Quantitative profiling of the full APOBEC3 mRNA repertoire in lymphocytes and tissues: implications for HIV-1 restriction publication-title: Nucleic Acids Res doi: 10.1093/nar/gkq174 – volume: 296 start-page: 550 year: 2002 ident: 2022060706540422400_bib22 article-title: A system for stable expression of short interfering RNAs in mammalian cells publication-title: Science doi: 10.1126/science.1068999 – volume: 195 start-page: 4565 year: 2015 ident: 2022060706540422400_bib14 article-title: APOBEC3 proteins in viral immunity publication-title: J Immunol doi: 10.4049/jimmunol.1501504 – volume: 35 start-page: 2955 year: 2007 ident: 2022060706540422400_bib28 article-title: All APOBEC3 family proteins differentially inhibit LINE-1 retrotransposition publication-title: Nucleic Acids Res doi: 10.1093/nar/gkm181 |
SSID | ssj0020176 |
Score | 2.3899066 |
Snippet | The APOBEC3 (A3) family of proteins are DNA cytidine deaminases that act as sentinels in the innate immune response against retroviral infections and are... |
SourceID | pubmedcentral proquest pubmed crossref |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source |
StartPage | 735 |
SubjectTerms | APOBEC Deaminases Cancer Cell Line, Tumor Cytidine Deaminase Cytosine Deaminase - genetics Cytosine Deaminase - metabolism Deoxyribonucleic acid DNA DNA damage Doxorubicin Gene expression Gene Expression Regulation - drug effects Gene regulation Genes Genomes Humans Immune response Immune system Innate immunity Interferon Interferon Type I - pharmacology Lymphocytes Mutants Mutation Neoplasms - genetics p53 Protein Proteins Transcription Tumor suppressor genes Tumor Suppressor Protein p53 - genetics Tumor Suppressor Protein p53 - metabolism |
Title | The Cytidine Deaminase APOBEC3 Family Is Subject to Transcriptional Regulation by p53 |
URI | https://www.ncbi.nlm.nih.gov/pubmed/28232385 https://www.proquest.com/docview/1983851675 https://www.proquest.com/docview/1872579660 https://www.proquest.com/docview/1911619037 https://pubmed.ncbi.nlm.nih.gov/PMC5457717 |
Volume | 15 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
journalDatabaseRights | – providerCode: PRVFSB databaseName: Free Full-Text Journals in Chemistry customDbUrl: eissn: 1557-3125 dateEnd: 20241001 omitProxy: true ssIdentifier: ssj0020176 issn: 1541-7786 databaseCode: HH5 dateStart: 20020101 isFulltext: true titleUrlDefault: http://abc-chemistry.org/ providerName: ABC ChemistRy – providerCode: PRVAFT databaseName: Open Access Digital Library customDbUrl: eissn: 1557-3125 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0020176 issn: 1541-7786 databaseCode: KQ8 dateStart: 20021101 isFulltext: true titleUrlDefault: http://grweb.coalliance.org/oadl/oadl.html providerName: Colorado Alliance of Research Libraries – providerCode: PRVBFR databaseName: Free Medical Journals customDbUrl: eissn: 1557-3125 dateEnd: 20241001 omitProxy: true ssIdentifier: ssj0020176 issn: 1541-7786 databaseCode: DIK dateStart: 20020101 isFulltext: true titleUrlDefault: http://www.freemedicaljournals.com providerName: Flying Publisher – providerCode: PRVFQY databaseName: GFMER Free Medical Journals customDbUrl: eissn: 1557-3125 dateEnd: 20241001 omitProxy: true ssIdentifier: ssj0020176 issn: 1541-7786 databaseCode: GX1 dateStart: 20020101 isFulltext: true titleUrlDefault: http://www.gfmer.ch/Medical_journals/Free_medical.php providerName: Geneva Foundation for Medical Education and Research |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db9MwELeqIRAvCMZXYSAj8TalxE4cJ4-lDG1IBTR10t6i2k62SlNarelD-Ef4d7mLHfdj02C8RFU-7KT3y935cvc7Qj5iH0peRmGgUpEGMYtZoJLEBCYVksUq1GXbbGL8PTk-i7-di_Ne7_dG1tKqVgP969a6kv-RKuwDuWKV7D0k6weFHfAb5AtbkDBs_1nGo6aeGXQVvxRTTGtBopGfPz4fjaKuqcXJEtUDxlvQ0WyNU6cqWmb9C9fBCz3RheXU7dzVcdc8F5PDdHF96LiBfAx5DKqyi0LbanUfXb5YNValTS5XTTCc-VhONVu4wH2zhtVpsaxcU3eXyX84HGyGJJhcp051WhREjsR01si4fQIDorbK2atesQGxTT0qLYeJM8nSMjnd1PYCKxj8bIPx6DTAuwmdFt5i196xej4XsV0FiTTHYXIcJodhcoaf5ZFO9gGXScJbjb8mcYRnbsvWupldaRgM8-nWu9l2em6sZHYTcjc8nMlT8sQtTejQ4uwZ6RXVPnlom5U2--TR2KVhPCdnADzaAY964FEHPGqBR0-W1AGP1nO6Azy6Bh5VDQXgvSBnX48mo-PA9ecINJjJOii0YqWMipQXYFNjk2SFKtk0yYwsmdIqLEUWpciFnRnNkcifK55xxvRUxwrGeEn2qnlVvCaUG6zcE2ADwD6UWZhpY1RmQhGaUgme9Enc_YG5duT12EPlKr9TfH0y8JctLHvL3y446KSTuxd9mbMsjWBhAkvrPvngD4Maxm9r06qYr-CcVHIs607CO84BxyIBBzySffLKCtzfFU9haQOz9IncgoI_AWngt49Us8uWDh7WQFIy-ea-z_qWPF6_vAdkr75eFe_Aw67V-xbtfwBEiccu |
linkProvider | ABC ChemistRy |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+Cytidine+Deaminase+APOBEC3+Family+Is+Subject+to+Transcriptional+Regulation+by+p53&rft.jtitle=Molecular+cancer+research&rft.au=Menendez%2C+Daniel&rft.au=Nguyen%2C+Thuy-Ai&rft.au=Snipe%2C+Joyce&rft.au=Resnick%2C+Michael+A.&rft.date=2017-06-01&rft.issn=1541-7786&rft.eissn=1557-3125&rft.volume=15&rft.issue=6&rft.spage=735&rft.epage=743&rft_id=info:doi/10.1158%2F1541-7786.MCR-17-0019&rft.externalDBID=n%2Fa&rft.externalDocID=10_1158_1541_7786_MCR_17_0019 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1541-7786&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1541-7786&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1541-7786&client=summon |